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The role of cellular proteases and endosome maturation in the entry of caliciviruses including porcine
enteric calicivirus (PEC), murine norovirus (MNV)-1 and feline calicivirus (FCV) were investigated.
Treatment with chloroquine or cathepsin L inhibitors, but not cathepsin B inhibitors, signiﬁcantly
reduced the replication of PEC, MNV and FCV. When concentrated PEC, MNV or FCV were incubated with
recombinant cathepsin L, the minor capsid protein VP2 of PEC and the major capsid protein VP1 of MNV
and FCV were cleaved by the protease based on the Western blot analysis. Confocal microscopy analysis
of PEC and MNV-1 showed that viral capsid proteins were retained in the endosomes in the presence of a
cathepsin L inhibitor or chloroquine during virus entry. The results of this study suggest the important
role of endosome maturation and cathepsin L in the entry of caliciviruses, and cathepsin L as a potential
therapeutic target for calicivirus infection.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Caliciviruses are nonenveloped viruses of 35–40 nm in dia-
meter and possess a single-stranded, positive-sense RNA genome
of approximately 7–8 kb (Green, 2007). Caliciviruses have a T¼3
icosahedral capsid assembled with 90 dimers of VP1 which is
composed of three domains; the N-terminal arm (NTA), the S
(shell) and the P (protruding) domains (Ng and Parra, 2010; Prasad
et al., 1999). The P domain of VP1 forms the spike on the virion and
is composed of P1 and P2 subdomains. The P2 subdomain is
located within the P1 subdomain and contains a conserved region
ﬂanked by the hypervariable domains (Prasad et al., 1999). The
hypervariable domains are mostly involved in receptor binding
(Bhella et al., 2008; Bhella and Goodfellow, 2011; Chen et al.,
2006). The function of VP2, a minor structural protein, is not well
known but it was reported that VP2 is required for the production
of infectious feline calicivirus (FCV) (Sosnovtsev et al., 2005),
interacts with VP1 to increase stability of norovirus capsid and is
likely to be associated with packaging of RNA genome (Bertolotti-
Ciarlet et al., 2003, 2002.
Caliciviruses belong to the family Caliciviridae which comprises
at least ﬁve genera including Norovirus, Sapovirus, Lagovirus,
Vesivirus, and Nebovirus (Green, 2007). Noroviruses and sapo-
viruses cause enteric infections in humans and animals (Green et
al., 2001). Lagoviruses and vesiviruses mainly cause oral, respira-
tory and sometimes systemic infections in animals (Green et al.,
2001). Noroviruses account for about 58% of foodborne human
illnesses causing about 21 million cases of gastroenteritis and 800
deaths annually in the United States alone (http://www.cdc.gov/
norovirus/about/overview.html). Despite the importance of noro-
virus in public health, research on understanding norovirus
biology and development of antiviral drugs has been greatly
hindered due to the inability to grow human noroviruses in cell
culture. Therefore, easily cultivable murine norovirus (MNV)
(Wobus et al., 2004) and FCV (Luttermann and Meyers, 2010), in
the family Caliciviridae, have been used as surrogate viruses for
studying noroviruses.
Virus entry is a multistep process that involves consecutive
interactions of cellular and viral factors including binding of virus
to cellular receptors, virus uncoating and release of viral genome to
initiate virus replication (Grove and Marsh, 2011; Marsh and
Helenius, 2006). Virus uncoating may occur at the plasma membrane
for direct penetration, or at the endosomes or other cellular compart-
ments (Marsh and Helenius, 2006). Viruses utilize a number of
different entry processes, including clathrin-dependent endocytic
pathway, clathrin-independent endocytic pathway that involves
caveolar or lipid, or other yet poorly deﬁned entry pathways
(Mercer et al., 2010). In clathrin-dependent endocytosis, viruses
taken up by clathrin-coated vesicles travel through the endocytic
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compartments fromwhere virus must escape before the increasingly
harsher environment of maturing endosomes irreversibly degrade
viruses. The journey of viruses following virus uptake to virus
uncoating and genome release is less well understood for viruses
that utilize clathrin-independent endocytosis (Grove and Marsh,
2011; Marsh and Helenius, 2006). However, there are reports that
subsequent sorting of endosomal cargo such as viruses in different
endocytic pathways may overlap in the early or late endosomes
(Naslavsky et al., 2004; Sharma et al., 2003).
In the endosomal compartments, host enzymes including
cathepsins are reported to be involved in virus fusion and/or
uncoating of virus capsid for some viruses (Grove and Marsh,
2011). The cathepsin family of proteolytic enzymes contains
several diverse classes of proteases including cysteine (cathepsins
B, L, H, K, S, and O), aspartyl (cathepsin D and E) and serine
(cathepsin G) proteases (Vasiljeva et al., 2007). Among them,
cathepsin L, B, or S have been reported to be associated with
entry and replication of some viruses including severe acute
respiratory syndrome (SARS) coronavirus, murine hepatitis virus,
reovirus and Ebola virus (Bosch et al., 2008; Brecher et al., 2012;
Ebert et al., 2002; Mainou and Dermody, 2012; Qiu et al., 2006;
Schornberg et al., 2006). Cathepsin L and B are shown to cleave
Ebola virus glycoprotein, leading to exposure of putative fusion
domain required for fusion of viral and endosomal membranes
(Schornberg et al., 2006). Cathepsin L is also reported to cleave the
spike protein of SARS coronavirus for fusion competence (Bosch et
al., 2008). In addition to the enveloped viruses that require
cathepsin for virus fusion and uncoating, some non-enveloped
viruses are also shown to rely on host cell proteases residing in the
endosomes for uncoating of virus capsid. Reovirus disassembly in
the endosomes is reported to be mediated predominantly by
cathepsin L and less efﬁciently by cathepsin B, generating infec-
tious subvirion particles that are capable of penetrating mem-
branes and deliver core particles into cytoplasm (Ebert et al., 2002;
Mainou and Dermody, 2012). Virus entry mechanisms for calici-
viruses including MNV-1, and porcine enteric calicivirus (PEC) or
human norovirus are not well understood to date, although it has
been shown that clathrin-dependent endocytosis and pH-
dependent entry is important in FCV replication (Kreutz and
Seal, 1995; Stuart and Brown, 2006). For MNV-1, it was reported
that MNV-1 entry is not mediated by clathrin or caveolae, but
dependent on dynamin and cholesterol (Gerondopoulos et al.,
2010; Perry et al., 2009; Perry and Wobus, 2010), but detailed
entry mechanism still needs further elucidation.
Here we demonstrated the importance of cathepsin L activity
and endosome maturation during the entry stage of caliciviruses
using PEC, FCV and MNV-1. We found that cathepsin L inhibitors,
but not a B inhibitor, and chloroquine signiﬁcantly reduced the
replication of PEC, FCV and MNV-1. We also found that recombi-
nant cathepsin L cleaved VP1 of FCV and MNV-1, and VP2 of PEC
based on the Western blot analysis. Confocal microscopy analysis
of PEC and MNV-1 showed that virus was retained in the
endosomes in the presence of a cathepsin L inhibitor or chlor-
oquine during virus entry. Our results suggest a crucial role of
cathepsin L in the replication of caliciviruses, and cathepsin L as a
potential therapeutic target for calicivirus infections.
Results
Inhibitors of cathepsin L, but not cathepsin B, signiﬁcantly reduced
the replication of caliciviruses
The role of cathepsin B and L in PEC, MNV-1 and FCV replica-
tion was studied using inhibitors of cathepsin L and cathepsin B.
Our results showed that treatment of cells with inhibitors of
cathepsin L (Z-FY-CHO and MDL 28170) reduced PEC titers by
32.6–106-fold, MNV-1 titers by 649.4–801.2-fold, and FCV titers by
25.1–39.8-fold (Fig. 1A–C). However, cathepsin B inhibitor CA074-
Me at up to 120 mM did not lead to a signiﬁcant reduction of viral
replication (Fig. 1A–C). Glycochenodeoxycholic acid (GCDCA), a
bile acid, was added to culture media for PEC replication, since PEC
Fig. 1. Effects of cathepsin inhibitors in the replication of PEC, MNV-1 or FCV. LLC-
PK, RAW267.4 or CRFK cells were incubated with cathepsin L inhibitors, Z-FY-CHO
and MDL 28170, or a cathepsin B inhibitor, CA074-Me, for 1 h, then infected with
(A) PEC (MOI 50) (B) MNV-1 (MOI 10) or (C) FCV (MOI 50) in the presence of each
inhibitor. For PEC, GCDCA (100 mM) was present in the media to support virus
replication during virus infection. Following virus infection for 1 h, cells were
washed and the media was replaced with fresh media containing an inhibitor. Cells
were further incubated at 37 1C and collected at 12 h PI. Viral replication was
quantiﬁed by the TCID50 assay. Asterisk indicates that virus titer was signiﬁcantly
reduced by an inhibitor compared to the control (Po0.05).
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does not grow in cell culture without bile acids (Chang et al., 2005,
2004) (Fig. 1A). The PEC levels in absence of bile acid and MNV-1
levels in cyclohexamide-treated cells indicate the levels of
internalized viruses (Fig. 1A and B). As reported previously,
CA074-Me signiﬁcantly reduced the replication of feline corona-
virus 1146 strain in CRFK cells (Kim et al., 2013; Regan et al., 2008)
(data not shown).
Endosomal acidiﬁcation is required for calicivirus replication
Since the maximal activity of cathepsin L requires acidic
condition at around pH 5 (Turk et al., 1993; Vasiljeva et al.,
2007), we studied the consequence of blocking endosomal acid-
iﬁcation in calicivirus replication using chloroquine. Our ﬁndings
indicate that the presence of chloroquine during 1 to 12 h post
infection (PI) resulted in a marked reduction in PEC replication by
46.3-fold, determined by the the 50% tissue culture infectious dose
(TCID50) assay (Fig. 2A). However, no statistically signiﬁcant
inhibitory effect was observed when chloroquine was added
during the later phase of virus replication cycle (at 6 h PI)
(Fig. 2A). Similar inhibitory effect of chloroquine was observed
for MNV-1: a 1334.9-fold reduction in viral load was observed
when chloroquine 70 mM was present continuously in the media,
but chloroquine 50 mM did not signiﬁcantly reduce MNV-1 repli-
cation (Fig. 2C). When chloroquine was present in the media at
high concentrations (100 or 200 mM) for a short time period,
greater reduction of virus replication was observed (Fig. 2B and C).
Figs. 1 and 2 contain only the TCID50 data, but the results obtained
by real time qRT-PCR (MNV or PEC genome copy numbers) were in
line with those with MNV or PEC TCID50 assay.
Cathepsin L, but not cathepsin B, cleaves calicivirus structural (major
or minor) protein
To study if cathepsin L and cathepsin B processes calicivirus
capsid proteins VP1 and VP2, concentrated PEC, MNV-1 and FCV
were incubated with recombinant cathepsin L or cathepsin B for
2 h at 37 1C. In Western blots, PEC VP1 and VP2 proteins were
detected as a single band of approximately 58 kDa and 18 kDa in
mock-incubated samples (Fig. 3). The Western blot analysis on the
samples incubated with cathepsin L or B showed that neither
enzyme cleaved PEC VP1 (Fig. 3). However, a band that corre-
sponds to a full length PEC VP2 (18 kDa) disappeared only in the
samples incubated with cathepsin L, suggesting cleavage by the
protease (Fig. 3). For MNV-1 and FCV, incubation of virus and
cathepsin L produced multiple bands in the Western blot analysis:
antibodies against FCV VP1 detected multiple fragments of
approximately 59 kDa (corresponding to a full length VP1),
36 kDa, 34 kDa and 23 kDa (Fig. 4), and antibodies against MNV-
1 VP1 detected two bands of approximately 59 kDa (correspond-
ing to a full length VP1) and 40 kDa (Fig. 4). However, cathepsin B
did not cleave FCV and MNV-1 VP1 (Fig. 4). Cleavage of virus
proteins was prevented by the presence of cathepsin L inhibitors
(Z-FY-CHO or MDL 28170) in the cathepsin L cleavage assay (data
not shown). FCV and MNV-1 VP2 cleavage by cathepsin L or B was
not studied due to unavailability of antibodies against VP2 of FCV
or MNV-1.
PEC or MNV-1 accumulated in the endosomes in the presence of a
cathepsin L inhibitor or chloroquine
PEC replication in cell culture is dependent on the presence of
bile acids in the media (Chang et al., 2005, 2004). However, the
mechanism of bile acid-supported PEC replication has not been
understood. In our recent report, we demonstrated that the
absence of bile acids (GCDCA) in cell culture or inhibition of
endosomal acidiﬁcation by chloroquine led to accumulation of
PEC in the endosomes, while PEC disappeared from the endo-
somes within 1 h of virus infection in bile acid-supplemented cell
Fig. 2. Effects of endosomal acidiﬁcation in the replication of PEC or MNV-1.
(A) LLC-PK cells were pre-treated with mock (medium) or chloroquine (70 mM) for
1 h, and infected with PEC (MOI 50) in the presence of mock or cholorquine. In all
cells, GCDCA (100 mM) was present in the media to support virus replication during
virus infection. Following virus infection, cells were thoroughly washed with PBS
and fresh medium containing mock or chloroquine was added to the cells. Cells
were then further incubated and collected at 12 h PI. In a separate experiment,
chloroquine was added to the PEC-infected cells at 6 h PI and cells were collected at
12 h PI for the determination of viral replication by the TCID50 assay. (B) RAW267.4
cells were pre-treated with mock (medium) or chloroquine (200 or 100 mM) for 30
min then infected with MNV-1 (MOI 10) in the presence of mock or chloroquine at
4 1C for 1 h. Cells were then washed with PBS and fresh medium containing mock
or chloroquine was added to the cells for further incubation at 37 1C. At 4 h PI, cells
were thoroughly washed again with PBS and fresh medium without chloroquine
was added to the cells. Cells were collected at 12 h PI for the determination of virus
replication by the TCID50 assay. (C) Cells were pretreated with chloroquine (50 or
70 mM) for 30 min , and infected with MNV-1 (10 MOI) in the presence of mock or
chloroquine at 4 1C for 1 h. Cells were then washed with PBS and fresh medium
containing chloroquine was added to the cells. Cells were further incubated and
collected at 12 h PI for determination of virus replication by the TCID50 assay. (A–C)
Asterisk indicates a signiﬁcant reduction of viral titers in the treatment group
compared to the control (Po0.05).
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culture (Shivanna et al., 2014). These results suggest that PEC
failed to escape from the endosomes in the absence of bile acids or
when endosomal maturation is inhibited. In this study, we
observed the similar phenomenon with cathepsin L inhibitor
treatment of the cells, indicated by colocalization of ﬂuorescently
labeled antibodies against PEC with Rab7, (Fig. 5). Rab7 is a GTPase
of a low molecular weight and mainly localized in the late
endosomes/lysosomes in mammalian cells, although it is also
associated with the early endosomes (Chavrier et al., 1990;
Soldati et al., 1995). The confocal images of PEC in cell culture in
the absence or presence of bile acids and chloroquine were
included as a reference in Fig. 5 (Shivanna et al., 2014). The cells
infected with PEC in the presence of GCDCA showed no or little
ﬂuorescence staining of PEC VP1 at 1 h PI, while relatively
abundant ﬂuorescence for PEC VP1 was detected in the cells
infected by PEC without GCDCA and in the cells treated with
chloroquine or a cathepsin L inhibitor Z-FY-CHO (Fig. 5). Confocal
microscopic analysis using MNV-1 also revealed similar results to
those shown with PEC infection. In RAW267.4 cells, no or little
MNV-1 were stained in the cytoplasm at 1 h PI (Fig. 6). However,
in the presence of Z-FY-CHO or chloroquine, MNV-1 VP1 was
detected at high abundance in the endosomes at 1 h PI (Fig. 6), a
similar observation made in PEC-infected cells (Fig. 5). These
results suggest that MNV-1, as well as PEC, failed to escape from
the endosomes in the presence of a cathepsin L inhibitor or
chloroquine. For quantitative statistical colocalization analysis,
single channel images were auto thresholded by Costes' auto
threshold method and Mander's split correlation coefﬁcients and
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Fig. 3. The effects of cathepsins on the cleavage of PEC VP1 and VP2. Concentrated PEC was incubated with a recombinant cathepsin L or cathepsin B in a cathepsin reaction
buffer at pH 4.0 or pH 5.5, respectively, for 2 h at 37 1C. Mock-treatment samples were incubated in PBS at pH 4, 5.5 or 7.0. The samples were then subjected to SDS-PAGE,
transferred to nitrocellulose membrane, probed with antibodies against PEC VP1 or VP2 and visualized by chemiluminescence. Uncleaved or cleaved VP1 and VP2 are
indicated by arrows.
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Fig. 4. The effects of cathepsins on the cleavage of VP1 of FCV or MNV-1. Concentrated FCV (left panel) or MNV-1 (right panel) was incubated with a recombinant cathepsin L
or cathepsin B in a cathepsin reaction buffer at pH 4.0 or pH 5.5, respectively, for 2 h at 37 1C. Mock-treatment samples were incubated in PBS at pH 4, 5.5 or 7.0. The samples
were then subjected to SDS-PAGE, transferred to nitrocellulose membrane, probed with antibodies against FCV or MNV-1 VP1 visualized by chemiluminescence. Uncleaved
or cleaved VP1 is indicated by an arrow.
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Pearson's correlation coefﬁcients for the endosomal marker Rab7
and MNV-1 or PEC were calculated to quantify the degree of
colocalization of viral proteins with Rab7 for all ﬂuorescence
confocal microscopy images. The calculated Mander's split corre-
lation coefﬁcients and Pearson's correlation coefﬁcients were
higher than 0.90 for all analyzed images.
Discussion
Virus entry is the ﬁrst step in virus replication cycle and is
characterized by complex interactions of cellular and viral factors
that subsequently lead to virus uncoating and release of viral
genome to initiate virus replication (Grove and Marsh, 2011;
Marsh and Helenius, 2006). In the limited number of studies
available on the entry process of caliciviruses, FCV entry has been
relatively well known, but the studies on the entry of other
caliciviruses such as human norovirus, PEC or MNV-1 have been
limited (Kreutz and Seal, 1995; Perry et al., 2009; Perry and
Wobus, 2010; Shivanna et al.,2014; Stuart and Brown, 2006). In
this study, we demonstrated that cathepsin L plays an important
role in the replication of PEC, FCV and MNV-1 by showing that
inhibition of cathepsin L, but not cathepsin B, led to a signiﬁcant
reduction in the replication of PEC, FCV and MNV-1 in cell culture.
It has been shown that cathepsin enzymes are involved in entry
and replication of some enveloped and non-enveloped viruses,
including SARS coronavirus, murine hepatitis virus, reovirus and
Ebola virus (Bosch et al., 2008; Brecher et al., 2012; Mainou and
Dermody, 2012; Qiu et al., 2006; Schornberg et al., 2006). How-
ever, the function of cathepsin in calicivirus entry has not been
previously reported. Once we found that inhibition of cathepsin L
function signiﬁcantly reduce the replication of the tested calici-
viruses, we determined if endosomal acidiﬁcation is important in
the replication of PEC and MNV-1, since cathepsin L requires acidic
pH for optimal activity, which may reﬂect their primary location in
the late endosomes/lysosomes (Honey and Rudensky, 2003; Turk
et al., 2000). For FCV, it was previously reported that maturation of
the endosomes is important in FCV replication (Kreutz and Seal,
1995; Stuart and Brown, 2006), and we conﬁrmed that FCV entry
is dependent on acidic pH (data not shown). PEC entry has not
been previously studied for chloroquine susceptibility and this is
the ﬁrst report that PEC entry requires acidic pH. Of note, MNV-1
entry was previously reported to be pH-independent by other
researchers (Gerondopoulos et al., 2010; Perry et al., 2009).
Our ﬁnding of the dependency of MNV-1 replication on acidiﬁca-
tion of the endosomes is contrast to previous reports, and the
reason for this discrepancy between our ﬁnding and others is
not clear, although thoroughly removing residual viruses after
virus infection was important for observing the inhibitory effects
of chloroquine.
Since it is a new ﬁnding that inhibition of cathepsin L function
during the early phase of virus replication causes a signiﬁcant
reduction of calicivirus replication in cell culture, we studied if
cathepsin L is capable of cleaving the structural proteins of PEC,
FCV and MNV-1. Based on Western blot analysis, cathepsin L
cleaved VP2 of PEC and VP1 of FCV and MNV-1 (Figs. 3 and 4).
Nuclei
Anti -
PEC
PEC + 
GCDCA + 
Chloroquine
PEC + 
GCDCA+
Z-FY-CHO
PEC +
GCDCAMock 
PEC w/o
GCDCA
Anti -
Rab7
Merged
Fig. 5. The effects of a cathepsin L inhibitor or chloroquine in PEC entry into the cells. Conﬂuent LLC-PK cells were pre-treated with mock (medium), Z-FY-CHO or
chloroquine for 30 min before virus inoculation. Cells were then inoculated with PEC (MOI 50) in the presence of mock, Z-FY-CHO or chloroquine. GCDCA (100 mM) was
present in cell culture during virus infection to support PEC replication, with the exception of mock-infected cells and PEC-infected negative control cells (PEC w/o GCDCA) .
Following virus infection for 1 h, cells were ﬁxed and probed with rabbit polyclonal anti-Rab7 or swine anti-PEC polyclonal antibodies, followed by secondary antibodies of
PerCP-Cy5.5 labeled secondary antibody against Rab7 (red, k–o) or FITC-labeled secondary antibody against PEC (green, f–j). Nuclei were stained with sytox orange (pseudo
colored blue, a–e). Confocal images on the prepared samples were obtained and colocalization analysis of PEC and Rab7 was performed using ImageJ software. In the merged
images (p–t), colocalization of PEC (green) and Rab7 (red) appears in white color.
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Although we do not know the signiﬁcance of FCV and MNV-1 VP1
cleavage by cathepsin L at the present moment, we may speculate
that VP1 cleavage by cellular enzymes such as cathepsin L
contributes to virus capsid uncoating process to allow release of
viral genome for virus replication. Our ﬁnding of cleavage of VP2 of
PEC by cathepsin L was an unexpected ﬁnding. The role of the
minor capsid protein VP2 is not clearly understood so far, however,
VP2 is implicated in the assembly of virus particle by correctly
forming capsid and/or increasing the stability of VP1 of FCV and
human noroviruses (Bertolotti-Ciarlet et al., 2003; Di Martino and
Marsilio, 2010). Therefore, it prompts us to speculate that VP2
cleavage by cathepsin L may contribute to destabilization of capsid.
Although the uncoating process of non-enveloped viruses is poorly
understood, reovirus, non-enveloped virus in the Reoviridae
family, has been studied well. Reovirus entry and productive
replication is dependent on cathepsin L and B for cleavage of
outer capsid proteins during entry, which leads to virus disas-
sembly and productive replication (Ebert et al., 2002; Mainou and
Dermody, 2012). We were not able to study the effects of cathepsin
enzymes on VP2 of FCV and MNV-1 for the lack of speciﬁc
antibodies, thus it remains to be determined if FCV and MNV-1
VP2 is also processed by cathepsin L or other cellular enzymes. It
also needs to be determined if PEC VP1 is processed by other
cellular enzymes.
Since cathepsin L primarily resides in the endosomes, we then
next studied the effects of cathepsin L inhibition on virus entry
using confocal microscopy. PEC replication is known to be
dependent on the presence of bile acids in cell culture, although
the role of bile acid in PEC replication has not been clear (Chang et
al., 2005, 2004). In our recent report, we demonstrated that bile
acids are required for PEC escape from the endosomes, and
endosomal acidiﬁcation/maturation is also essential for the func-
tion of bile acid in the endosomes and/or is independently
contribute to virus endosomal escape (Shivanna et al., 2014).
In this study, we observed similar phenomenon of virus entrapment
of MNV-1 and PEC on confocal microscopy: inhibition of cathepsin
L or endosomal acidiﬁcation led to accumulation of MNV-1 or PEC
in the endosomes, preventing virus endosomal escape to initiate
virus replication (Figs. 5 and 6). These results demonstrate that
cathepsin L activity in the low pH environment is important for
calicivirus entry and subsequent replication, and are consistent
with the ﬁndings of a signiﬁcant reduction of virus titers by
treatment of cells with cathepsin L inhibitors or chloroquine in
the cell culture.
Here we report a new ﬁnding that cathepsin L activity is
important in virus replication and endosomal escape of calici-
viruses, including FCV, MNV-1, and PEC, based on the cathepsin
inhibitor study, capsid cleavage assay, and confocal microscopy
study. These results allow us to speculate that the entry pathways
of caliciviruses may share a common step of interactions of virus
and cathepsin for virus uncoating and/or viral escape from the
endosomes, and may also shed an important insight to the entry of
other caliciviruses, including human noroviruses which are major
public health concerns.
Mock
Anti-
MNV-1
MNV-1  +
Z-FY-CHO
MNV-1  +
Chloroquine
Nucleus
MNV-1
Rab-7
Merged
Fig. 6. The effects of cathepsin L inhibitor or chloroquine in MNV-1 entry into the cells. RAW267.4 cells were pre-treated with mock (medium), Z-FY-CHO or chloroquine for
30 min before MNV-1 inoculation (MOI 10). Following virus infection at 37 1C for 1 h, cells were ﬁxed and probed with rabbit polyclonal anti-Rab7 or guinea pig polyclonal
antibody against MNV-1, followed by PerCP-Cy5.5 labeled secondary antibody against Rab7 (red, i–l) or FITC-labeled secondary antibody against MNV-1 (green, e–h). Nuclei
were stained with sytox orange (pseudo colored blue, a–d). Confocal images on the prepared samples were obtained and colocalization analysis of Rab7 and MNV-1 was
performed by ImageJ software. In the merged images (p–t), colocalization of MNV-1 (green) and Rab7 (red) appears in white color.
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Materials and methods
Cell culture and viruses
Cell culture adapted PEC Cowden strain was propagated in pig
kidney epithelial cells (LLC-PK) in the presence of GCDCA
( 100 mM) in Eagle's Minimal Essential Medium (MEM) supple-
mented with 5% fetal bovine serum (FBS), 100 U/ml penicillin and
100 mg/ml streptomycin. FCV Urbana strain was propagated in
Crandell Rees feline kidney (CRFK) cells in MEM containing 5% FBS,
penicillin (100 U/ml) and streptomycin (100 mg/ml). MNV-1 was
propagated in RAW 264.7 cells (Wobus et al., 2004) with Dulbec-
co's modiﬁed Eagle's medium (DMEM) supplemented with 5% FBS,
penicillin (100 U/ml) and streptomycin (100 mg/ml). Each virus
was concentrated prior to infection by centrifuging viruses at
27,000 RPM through a 40% w/v sucrose cushion at 4 1C for 2 h. The
pellet was reconstituted in serum free MEM and stored at 80 1C.
Feline coronavirus WSU-1146 strain, which is reported to be
susceptible to a cathepsin B inhibitor, was obtained from ATCC.
Reagents and antibodies
GCDCA and chloroquine were purchased from Sigma-Aldrich
(St Louis, MO). Cathepsin L inhibitors, Z-FY-CHO and MDL 28170,
were purchased from Santa Cruz Biotech (Santa Cruz, CA), and a
cathepsin B inhibitor CA074-Me was purchased from Sigma-
Aldrich. Recombinant human cathepsin L and cathepsin B were
purchased from R & D systems (Minneapolis, MN). The primary
antibodies used in this study were anti-PEC/Cowden antibodies
raised in swine (Chang et al., 2005), anti-PEC VP2 antibodies raised
in guinea pig (Chang et al., 2005), anti-FCV antibodies raised in
guinea pig (Sosnovtsev and Green, 1995), anti-MNV-1 antibodies
raised in guinea pig (Wobus et al., 2004) and anti-Rab7 antibodies
(Santa Cruz Biotech, CA). The secondary antibodies for Western
blot analysis included horseradish peroxidase-conjugates of anti-
swine Ig and anti-guinea pig Ig antibody (Thermo Scientiﬁc,
Pittsburgh, PA). The secondary antibodies for confocal microscopy
were FITC-labeled anti-swine IgG for PEC (Kirkegaard & Perry Lab
Inc, MD), FITC-labeled anti-guinea pig IgG for MNV-1 (Sigma-
Aldrich, MO) and anti-rabbit PerCP-Cy5.5 (Santa Cruz Biotech, CA).
Other basic chemicals for confocal microscopy and other studies
were purchased from various sources including Sigma-Aldrich.
Effects of inhibition of cathepsin B or L activities in calicivirus replication
Conﬂuent LLC-PK cells cultured in 12 well plates were pre-
treated with inhibitors of cathepsin L (Z-FY-CHO 120 mM; MDL
28170, 100 mM) or cathepsin B (CA074-Me, 120 mM) for 1 h. Cells
were then infected with PEC Cowden strain at a multiplicity of
infection (MOI) of 50 in the presence of 100 mM GCDCA and a
cathepsin inhibitor L or B at 37 1C. After 1 h, cell monolayer was
washed twice with PBS and the medium was replaced with fresh
medium containing a cathepsin L or B inhibitor at the same
concentration. The cells were further incubated at 37 1C. At 12 h
PI, cells were subjected to repeated freezing and thawing for virus
titration using the TCID50 assay (Reed and Muench, 1938), or total
RNA was extracted from the cells for real time qRT-PCR as
described previously (Shivanna et al., 2014). The primers and
probe sets used for real time qRT-PCR are listed in Table 1. Viral
genome copy number was calculated from an external standard
curve that was generated by plotting the Ct values vs. ten-fold
dilutions of a known concentration of PEC RNA (Chang et al.,
2005).
The effect of each inhibitor on the replication of FCV and MNV-
1 was also studied following a similar experimental method. CRFK
and RAW267.4 cells were preincubated with Z-FY-CHO (40 mM),
MDL 28170 (80 mM), or CA074-Me (40 mM) for 1 h prior to
inoculation of FCV (MOI 50) or MNV-1 (MOI 10). Following virus
infection for 1 h, cells were washed with PBS and fresh medium
containing an inhibitor was added to the cells. In a separate
experiment, cells were preincubated with cyclohexamide
(100 mg/ml) for 1 h prior to MNV-1 infection to monitor the levels
of internalized virus without further virus replication. At 12 h PI,
virus replication was monitored by the TCID50 assay (MNV-1 and
FCV) or real time qRT-PCR (MNV-1). The inhibitors at the con-
centrations used in this study showed minimal cytotoxicity at 12 h
PI in LLC-PK, CRFK and RAW267.4 cells. Because cathepsin B
inhibitor CA074-Me blocks the replication of feline coronavirus
(Kim et al., 2013; Regan et al., 2008), feline coronavirus 1146 strain
was included in this study as a control and virus replication was
monitored by the TCID50 assay (Kim et al., 2013).
Effects of inhibition of endosomal acidiﬁcation in calicivirus
replication
Conﬂuent LLC-PK cells cultured in 12 well plates were pre-
treated with mock (medium) or an inhibitor of endosomal acid-
iﬁcation (chloroquine, 70 mM) for 1 h. Cells were then infected
with PEC at an MOI of 50 in the presence of chloroquine or mock at
37 1C. Since PEC does not replicate without bile acid, GCDCA
(100 mM, ﬁnal concentration) was added to the media during virus
infection. Following virus infection for 1 h, cell monolayer was
thoroughly washed three times with PBS and the medium was
replaced with fresh medium containing the same concentration of
chloroquine or mock. In other experiments, chloroquine was
added at 6 h PI to determine its effect at later stages of virus
replication. Chloroquine at this concentration (70 mM) was mini-
mally cytotoxic in LLC-PK cells. At 12 PI, cells were subjected to
repeated freezing and thawing for virus titration using the TCID50
assay, or total RNA was extracted for real time qRT-PCR.
The effect of chloroquine on the replication of MNV-1 was also
studied following the similar experimental design using RAW267.4
cells. Cells were pre-treated with chloroquine at 50 or 70 mM at
37 1C for 30 min, and infected with MNV-1 at an MOI of 10 in the
presence of chloroquine or mock (medium) at 4 1C. Following 1 h
incubation, cells were thoroughly washed three times with PBS,
and the same concentration of chloroquine or mock was added
into the media. In another set of experiments, high concentrations
of chloroquine (100 or 200 mM) were added to the media for
30 min prior to MNV-1 infection at an MOI of 10,
and the media was removed at 4 h PI by thoroughly washing
the cells with PBS to minimize cytotoxicity (Perry et al., 2009).
In all experiments, cells were subjected to repeated freezing and
thawing at 12 h PI for virus titration using the TCID50 assay and
real time qRT-PCR.
In-vitro cleavage of viral proteins by cathepsin
Concentrated PEC, FCV or MNV-1 was incubated with or with-
out recombinant human cathepsin L (0.64 mg) or cathepsin B
Table 1
The primers and probes used for real time qRT-PCR for PEC and MNV-1.
Name Sequences (5'-3')
PEC qRT-PCRa F: ATTCCAGAGTTGACCCACAG
R: CTACTGGGTTGATGGCGAC
P: 6-FAM/TGGTATAGATTAAGAGGCACAGCGGC/IABkFQ
MNV-1 qRT-PCR F: CATAGATGCCCCTGGAGTAAAG
R: CTCTCCAACATCTTCGCTCTG
P: 6-FAM/CATGATGACCACCTGCTCCACCTT/IABkFQ
a F: forward primer; R: reverse primer; P: probe.
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(0.64 mg) in reaction buffer containing 100 mM Na acetate, 1 mM
EDTA, and 4 mM DTT at pH 4.0 (for cathepsin L) or pH 5.5 (for
cathepsin B), or concentrated viruses were incubated in PBS (pH
7.0) for 2 h at 37 1C. To assess the cathepsin L inhibitors in in-vitro
cathepsin L cleavage of PEC, FCV or MNV-1 capsid proteins, Z-FY-
CHO or MDL 28170 was added to the cathespin L cleavage assay at
200 mM (ﬁnal concentration). The samples were then mixed with
1 LDS sample buffer (Invitrogen) containing 2-mercaptoethanol,
and heated to 95 1C for 5 min. Following heat treatment, the
samples were subjected to SDS-PAGE (12% Tris-glycine) and
proteins were transferred to nitrocellulose membranes. Membranes
were probed with primary antibodies followed by horseradish
peroxidase-conjugated species-speciﬁc secondary antibodies. Pro-
teins were visualized by chemiluminescence according to the man-
ufacturer's instructions (Thermo Scientiﬁc).
Confocal laser scanning microscopy
To study the effects of a cathepsin L inhibitor (Z-FY-CHO) or
chloroquine during the entry of PEC or MNV-1, virus trafﬁcking
was monitored using confocal microscopy (Shivanna et al., 2014).
LLC-PK or RAW267.4 cells were seeded onto a Lab-Tek II CC2
chamber slide (Fisher Scientiﬁc) treated with FBS and grown to
90% conﬂuency. Conﬂuent cells on the chamber slides were
treated with mock (medium), chloroquine (100 mM) or Z-FY-CHO
(100 mM) for 30 min. PEC or MNV-1 was then inoculated to the
cells at an MOI of 50 or 10, respectively, and the cells were further
incubated at 37 1C for 1 h. In LLC-PK cells, GCDCA (100 mM) was
added to the media at the time of virus inoculation. At 1 h PI, cells
were ﬁxed in 4% paraformaldehyde (Sigma-Aldrich) in PBS (pH
7.4) for 15 min at room temperature (RT), permeabilized with 0.1%
Triton-100 in PBS for 10 min at RT, washed three times with PBS,
and incubated in blocking buffer [PBS containing 0.5% bovine
serum albumin] for 15 min. The cells were then incubated with
primary antibodies speciﬁc to PEC (1:200), MNV-1 (1:200) or Rab7
(1:200) at 37 1C to probe PEC, MNV-1 and the endosomes,
respectively. After 2 h incubation, cells were washed three times
with PBS and further incubated at 37 1C for 2 h with FITC-labeled
anti-swine IgG or anti-guinea pig IgG against PEC or MNV-1,
respectively. For Rab7, PerCP-Cy5.5 labeled anti-rabbit IgG was
used as a secondary antibody. The same cells were also stained
with sytox orange (Life technologies) DNA stain (0.5 mM in 0.9%
NaCl). Coverslips were mounted in Prolong Gold antifade reagent
(Molecular Probes), and the cells were scanned with a confocal
microscope LSM 510 (Zeiss, Oberkochen, Germany) using a 100
oil-immersion objective. The images were analyzed by ImageJ
software 1.47 (http://imagej.nih.gov/ij/), and colocalization analy-
sis was performed using JACoP and colocalization-MBF plugins for
ImageJ software. Single channel images were thresholded by
Costes' auto threshold method and the Mander's split correlation
coefﬁcient and Pearson's correlation coefﬁcient for colocalization
was then determined for each image.
Statistical analysis
The effects of cathepsin or endosomal acidiﬁcation inhibitors in
virus replication were compared to the mock treatment using a two-
tailed Student's t-test. P valueo0.05 was considered statistically
signiﬁcant. Data were from at least three independent experiments.
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